Intravacc to develop intranasal gonorrhea vaccine with $14.6M NIH/NIAID contract
Intravacc has been awarded a contract with base and options that may total US$14.6 million…
Intravacc has been awarded a contract with base and options that may total US$14.6 million…
This week we're traveling to Bergen, a beautiful coastal city in Norway surrounded by seven…
The RAIDs consortium made its closing event last week. After 4.5 years of studies, it…
Hookipa just secured a huge grant from the Austrian government. The plan is to develop…
Transgene is partnering with Merck and Pfizer to develop a combined therapy for head and…
Genticel has announced that not one but two milestones have been achieved in the development…
Estonia, our previous destination by the Baltic Sea, was a delightful and a full of…
Genticel (France) is a clinical biotech developing a cervical cancer immunotherapy against the Human papillomavirus. However, their 24-month phase…
The Dutch Oncology VC Specialist Aglaia has invested €3.4M in the Swiss Start-Up Inthera Bioscience…
Genticel is a step closer to prevent cancer caused by the human papillomavirus (HPV). The…